Stockscreener 앱 받기
12.01
26.29%
2.50
시간 외 거래:
11.95
-0.06
-0.50%
전일 마감가:
$9.51
열려 있는:
$10.83
하루 거래량:
22.25M
Relative Volume:
4.27
시가총액:
$4.71B
수익:
$4.45B
순이익/손실:
$205.00M
주가수익비율:
30.02
EPS:
0.4
순현금흐름:
$372.00M
1주 성능:
+26.69%
1개월 성능:
+34.34%
6개월 성능:
-17.17%
1년 성능:
-11.17%
1일 변동 폭
$10.75
$12.14
1주일 범위
$9.32
$12.14
52주 변동 폭
$8.02
$18.80
엘란코 Stock (ELAN) Company Profile
명칭
Elanco Animal Health Inc
전화
877-352-6261
주소
2500 INNOVATION WAY, GREENFIELD
ELAN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
12.01 | 4.71B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
155.99 | 69.76B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.06 | 48.12B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.76 | 45.75B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.60 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
306.92 | 13.67B | 2.76B | 1.11B | 898.10M | 22.77 |
엘란코 Stock (ELAN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-09 | 개시 | UBS | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Market Perform |
| 2024-09-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-19 | 개시 | Jefferies | Buy |
| 2023-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-04-20 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-08-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Sell |
| 2022-07-12 | 개시 | Piper Sandler | Neutral |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-10-28 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2021-05-11 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 개시 | Stifel | Buy |
| 2021-03-22 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2021-02-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | 다운그레이드 | Argus | Buy → Hold |
| 2020-11-09 | 다운그레이드 | Barclays | Overweight → Underweight |
| 2020-08-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 재개 | Credit Suisse | Neutral |
| 2020-08-04 | 재개 | Goldman | Buy |
| 2020-07-27 | 다운그레이드 | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 개시 | Barclays | Overweight |
| 2019-08-26 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2019-05-23 | 개시 | Guggenheim | Neutral |
| 2019-03-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 재개 | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 개시 | William Blair | Mkt Perform |
| 2019-01-23 | 개시 | UBS | Sell |
| 2019-01-15 | 개시 | Argus | Buy |
| 2018-10-15 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
엘란코 주식(ELAN)의 최신 뉴스
Decoding Elanco Animal Health Inc (ELAN): A Strategic SWOT Insig - GuruFocus
Health Care Stocks Climb As Companies Show Strong Gains - Finimize
Elanco (ELAN) Stock Target Raised by Analyst Amid Favorable Quarter | ELAN Stock News - GuruFocus
Elanco Animal Health (ELAN) Sees Strong Q1 Performance and Raises Outlook - GuruFocus
Elanco (ELAN) Stock Trades Up, Here Is Why - Yahoo Finance
Animal Health Elanco Chirps A Solid Quarter Tempered By Soft Q2 EPS Guide - Benzinga
Elanco Animal Health (ELAN) Raises Full-Year Revenue Outlook - GuruFocus
Transcript : Elanco Animal Health Incorporated, Q1 2025 Earnings Call, May 07, 2025 - marketscreener.com
Compared to Estimates, Elanco Animal Health (ELAN) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Elanco Animal Health Inc SEC 10-Q Report - TradingView
Elanco stock spikes after Q1 beat (ELAN:NYSE) - Seeking Alpha
Elanco Animal Health Beats Q1 Estimates, Faces Revenue Growth ChallengesNews and Statistics - IndexBox
Elanco (ELAN) Beats Earnings Estimates, Raises 2025 Revenue Guidance - GuruFocus
Elanco Animal Health Incorporated (ELAN) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
Elanco Q1 2025 slides: Revenue guidance raised amid innovation-driven growth - Investing.com Canada
Elanco Animal Health beats Q1 estimates, shares rise over 3% By Investing.com - Investing.com South Africa
Elanco Animal Health beats Q1 estimates, shares rise over 3% - Investing.com Australia
Elanco (ELAN) Revises 2025 Revenue Forecast and Affirms Profit Projections | ELAN Stock News - GuruFocus
Elanco Animal Health Inc (ELAN) Q1 2025 Earnings: EPS of $0.13 Beats Estimate, Revenue at $1,193 Million Surpasses Expectations - GuruFocus
Elanco (NYSE:ELAN) Beats Q1 Sales Targets, Full-Year Outlook Slightly Exceeds Expectations - Yahoo Finance
Elanco (ELAN) Reports Strong Q1 Revenue with Raised 2025 Guidance | ELAN Stock News - GuruFocus
Elanco Animal Health Reports First Quarter 2025 Results | ELAN Stock News - GuruFocus
Elanco Animal Health Reports First Quarter 2025 Results - TradingView
Elanco Animal Health Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Acquired by First Trust Advisors LP - Defense World
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL.com
Companion Animal Vaccine Market Is Booming So Rapidly 2025-2032 - openPR.com
Elanco (ELAN) Reports Q1: Everything You Need To Know Ahead Of Earnings - FinancialContent
Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal - Yahoo
Commit To Buy Elanco Animal Health At $8, Earn 13.1% Using Options - Nasdaq
Elanco Sells Xdemvy Royalty, Milestone Rights to Blackstone Affiliates for $295 Million - marketscreener.com
Elanco Sells Royalty and Milestone Rights for Lotilaner in Human - GuruFocus
Elanco Sells Royalty, Milestone Rights For Lotilaner In Human Health To Blackstone For $295 Mln Cash - Nasdaq
Elanco Sells Royalty And Milestone Rights For Lotilaner In Human Health To Blackstone Accelerates Debt Paydown - marketscreener.com
Elanco Cuts Debt With $295M Blackstone Deal: Key Details on Leverage Target and XDEMVY Royalty Sale - Stock Titan
Analyzing Ratios: Elanco Animal Health Inc (ELAN)’s Financial Story Unveiled - DWinneX
Renaissance Technologies LLC Has $760,000 Position in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Cyromazine Market Deep Research Report with Forecast by 2032 | - openPR.com
Elanco Animal Health Inc [ELAN] Shares Fall Approximately -28.51% Over the Year - knoxdaily.com
Earnings Preview: Elanco Animal Health Incorporated (ELAN) Q1 Earnings Expected to Decline - Yahoo Finance
Companion Animal Specialty Drugs Market Is Booming So Rapidly | Elanco, Dechra, Zomedica - openPR.com
Mariner LLC Buys 24,901 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
ELANCO ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Elanco Board Sued Over Safety, FDA Setbacks for Dog Itch Drug - Bloomberg Law News
Elanco Animal Health Inc (ELAN) Stock: A Comprehensive 52-Week Review - investchronicle.com
ELAN’s price-to-book ratio: An indicator of the company’s performance - uspostnews.com
A History of Outperforming Analyst Forecasts and Beating the Odds: Elanco Animal Health Inc (ELAN) - Sete News
Poultry Antibiotic Market Set to Witness Significant Growth - openPR.com
Press Release Distribution & PR Platform - ACCESS Newswire
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Purchased by Envestnet Asset Management Inc. - Defense World
Russell Investments Group Ltd. Decreases Stake in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
엘란코 (ELAN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.07%
23.23%
자본화:
|
볼륨(24시간):